Jef C.M. Raus

786 total citations
19 papers, 663 citations indexed

About

Jef C.M. Raus is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Oncology. According to data from OpenAlex, Jef C.M. Raus has authored 19 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Radiology, Nuclear Medicine and Imaging, 14 papers in Immunology and 4 papers in Oncology. Recurrent topics in Jef C.M. Raus's work include Monoclonal and Polyclonal Antibodies Research (14 papers), T-cell and B-cell Immunology (8 papers) and Toxin Mechanisms and Immunotoxins (5 papers). Jef C.M. Raus is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (14 papers), T-cell and B-cell Immunology (8 papers) and Toxin Mechanisms and Immunotoxins (5 papers). Jef C.M. Raus collaborates with scholars based in Belgium, United States and Netherlands. Jef C.M. Raus's co-authors include Robert Medaer, George A. Hashim, Ella van den Berg‐Loonen, Anthony Rosenzweig, Dan Lehmann, Lydia Cohen, Roland Liblau, Hennie R. Hoogenboom, Elisabeth Tournier‐Lasserve and Avraham Ben‐Nun and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Jef C.M. Raus

19 papers receiving 652 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jef C.M. Raus Belgium 12 486 213 169 134 80 19 663
Joyce A. Schroer United States 10 344 0.7× 280 1.3× 239 1.4× 47 0.4× 47 0.6× 18 666
Gabriella Huerta United States 5 410 0.8× 325 1.5× 320 1.9× 139 1.0× 70 0.9× 5 736
Gabriele Combriato Germany 14 288 0.6× 280 1.3× 371 2.2× 55 0.4× 61 0.8× 17 695
Dilduz Telman United States 6 429 0.9× 389 1.8× 354 2.1× 237 1.8× 77 1.0× 6 817
Peter Verheesen Netherlands 13 155 0.3× 296 1.4× 357 2.1× 119 0.9× 30 0.4× 21 794
Rhonda B. Lang United States 8 294 0.6× 263 1.2× 314 1.9× 39 0.3× 62 0.8× 8 589
Diana Ronai United States 10 323 0.7× 91 0.4× 341 2.0× 68 0.5× 56 0.7× 14 601
W J Boersma Netherlands 7 552 1.1× 98 0.5× 186 1.1× 81 0.6× 96 1.2× 7 857
Michael S. Cole United States 10 378 0.8× 329 1.5× 231 1.4× 17 0.1× 158 2.0× 12 650
Dominique Poujol France 9 267 0.5× 155 0.7× 231 1.4× 19 0.1× 157 2.0× 12 501

Countries citing papers authored by Jef C.M. Raus

Since Specialization
Citations

This map shows the geographic impact of Jef C.M. Raus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jef C.M. Raus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jef C.M. Raus more than expected).

Fields of papers citing papers by Jef C.M. Raus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jef C.M. Raus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jef C.M. Raus. The network helps show where Jef C.M. Raus may publish in the future.

Co-authorship network of co-authors of Jef C.M. Raus

This figure shows the co-authorship network connecting the top 25 collaborators of Jef C.M. Raus. A scholar is included among the top collaborators of Jef C.M. Raus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jef C.M. Raus. Jef C.M. Raus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Newton, Dianne L., Paul DiTullio, Yann Echelard, et al.. (1999). Antitransferrin receptor antibody-RNase fusion protein expressed in the mammary gland of transgenic mice. Journal of Immunological Methods. 231(1-2). 159–167. 28 indexed citations
2.
Nicholls, P J, V G Johnson, Sarah M. Andrew, et al.. (1993). Characterization of single-chain antibody (sFv)-toxin fusion proteins produced in vitro in rabbit reticulocyte lysate.. Journal of Biological Chemistry. 268(7). 5302–5308. 38 indexed citations
3.
Medaer, Robert, et al.. (1992). Myelin basic protein–specific T lymphocytes in multiple sclerosis and controls: Precursor frequency, fine specificity, and cytotoxicity. Annals of Neurology. 32(3). 330–338. 129 indexed citations
4.
Rybak, S.M., H.R. Hoogenboom, Harry Meade, et al.. (1992). Humanization of immunotoxins.. Proceedings of the National Academy of Sciences. 89(8). 3165–3169. 55 indexed citations
5.
Rybak, Susanna M., Hennie R. Hoogenboom, Dianne L. Newton, Jef C.M. Raus, & Richard J. Youle. (1992). Rational immunotherapy with ribonuclease chimeras. Cell Biophysics. 21(1-3). 121–138. 6 indexed citations
6.
Medaer, Robert, et al.. (1992). Regulation of myelin basic protein-specific helper T cells in multiple sclerosis: Generation of suppressor T cell lines. Cellular Immunology. 139(1). 118–130. 9 indexed citations
7.
Hoogenboom, Hennie R., et al.. (1991). Construction and expression of antibody-tumor necrosis factor fusion proteins. Molecular Immunology. 28(9). 1027–1037. 33 indexed citations
8.
Hoogenboom, Hennie R., Jef C.M. Raus, & Guido Volckaert. (1991). Targeting of tumor necrosis factor to tumor cells: secretion by myeloma cells of a genetically engineered antibody-tumor necrosis factor hybrid molecule. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1096(4). 345–354. 22 indexed citations
9.
Ben‐Nun, Avraham, Roland Liblau, Lydia Cohen, et al.. (1991). Restricted T-cell receptor V beta gene usage by myelin basic protein-specific T-cell clones in multiple sclerosis: predominant genes vary in individuals.. Proceedings of the National Academy of Sciences. 88(6). 2466–2470. 178 indexed citations
10.
11.
Hoogenboom, Hennie R., Jef C.M. Raus, & G. Volckaerţ. (1990). Cloning and expression of a chimeric antibody directed against the human transferrin receptor.. The Journal of Immunology. 144(8). 3211–3217. 28 indexed citations
12.
Hashim, George A., et al.. (1990). Preferential peptide specificity and HLA restriction of myelin basic protein-specific T cell clones derived from MS patients. Cellular Immunology. 129(1). 189–198. 30 indexed citations
13.
Weber, Wim E.J., et al.. (1989). A common epitope on human myelin basic protein and the human T lymphocyte CD3 molecule.. The Journal of Immunology. 142(11). 3917–3922. 7 indexed citations
14.
Weber, Wim E.J., Marc Vandermeeren, Jef C.M. Raus, & Wim A. Buurman. (1989). Human myelin basic protein-specific cytolytic T lymphocyte clones are functionally restricted by HLA class II gene products. Cellular Immunology. 120(1). 145–153. 7 indexed citations
15.
Vandenbark, Arthur A., et al.. (1989). Murine monoclonal anti-myelin basic protein (MBP) antibodies inhibit proliferation and cytotoxicity of MBP-specific human T cell clones. Journal of Neuroimmunology. 24(1-2). 87–94. 13 indexed citations
16.
Vandenbark, Arthur A., et al.. (1989). Human B cell lines secreting IgM antibody specific for myelin basic protein. Journal of Neuroimmunology. 24(1-2). 9–16. 8 indexed citations
17.
Weber, Wim E.J., W. A. Buurman, M. Vandermeeren, R. Medaer, & Jef C.M. Raus. (1987). Fine analysis of cytolytic and natural killer T lymphocytes in the CSF in multiple sclerosis and other neurologic diseases. Neurology. 37(3). 419–419. 14 indexed citations
18.
Weber, Wim E.J., Wim A. Buurman, M. Vandermeeren, & Jef C.M. Raus. (1985). Activation through CD3 molecule leads to clonal expansion of all human peripheral blood T lymphocytes: functional analysis of clonally expanded cells.. The Journal of Immunology. 135(4). 2337–2342. 46 indexed citations
19.
Raus, Jef C.M., et al.. (1983). Superfusion of Normal and Neoplastic Mouse Mammary Tissue with Estrogens. Endocrinology. 113(1). 399–408. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joyce A. Schroer Breakdown of academic impact, for papers by Gabriella Huerta Breakdown of academic impact, for papers by Gabriele Combriato Breakdown of academic impact, for papers by Dilduz Telman Breakdown of academic impact, for papers by Peter Verheesen Breakdown of academic impact, for papers by Rhonda B. Lang Breakdown of academic impact, for papers by Diana Ronai Breakdown of academic impact, for papers by W J Boersma Breakdown of academic impact, for papers by Michael S. Cole Breakdown of academic impact, for papers by Dominique Poujol
Rankless by CCL
2026